Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
about
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisHIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsExpanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, CanadaUniversal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costsEarly identification of HIV: empirical support for jail-based screeningLeveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction.Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China.Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan AfricaA universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures StudyAddressing research priorities for prevention of HIV infection in the United StatesAntiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysisCross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiModelling sexual transmission of HIV: testing the assumptions, validating the predictions.Modeling scenarios for the end of AIDSCombining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi.How HIV treatment could result in effective preventionTreatment to prevent transmission of HIV-1Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.HIV treatment as prevention: the key to an AIDS-free generation.Engaging men in prevention and care for HIV/AIDS in AfricaA mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.HIV treatment as prevention: the utility and limitations of ecological observation.Antiretroviral therapy use among HIV-infected men who have sex with men attending a sexually transmitted diseases clinic.Expanded Highly Active Antiretroviral Therapy Coverage - A Powerful Strategy to Curb Progression to AIDS, Death and New InfectionsEstimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelEstimated HIV Incidence in California, 2006-2009Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020.Treatment as prevention--where next?Correlates of unstructured antiretroviral treatment interruption in a cohort of HIV-positive individuals in British Columbia.Rethinking prevention of HIV type 1 infection.HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysisAIDS vaccines and preexposure prophylaxis: is synergy possible?The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.
P2860
Q22241321-FADE8FE7-1EB1-4E93-9BB4-889CA4E04946Q26828443-EA6840C7-C88B-4B4B-A68E-61D9F30B1477Q28080917-694E7D64-6746-4442-9A3E-639BA0D7D114Q28474271-2D00C169-6BD5-4A0A-B561-3FD0414FF284Q28483485-3D0E0AA5-EE91-4181-9EB6-758D87700561Q28483957-91FE7E9E-B34E-4E3C-8E27-883E0073E347Q30363573-B695165D-1C64-4849-807D-F38E3AB5B165Q30666487-D633F2E5-B8F9-4A6D-B785-2FCD18F867E3Q33562524-713A1C0C-9576-466B-BAA3-18B1CE1E2294Q33604727-62ADDAA2-6E81-419E-9870-884EF89ACCF9Q33625803-70EECB03-6C9A-485F-825D-53A056ED5C4DQ33626374-499FA14A-9937-4FD1-B37F-1ED350098C55Q33804916-8CA4916F-81A6-4E58-8804-C6CD24DAAB85Q33822456-4EB68472-6150-48C6-A786-4A23BCCCD2B2Q33831138-9CD9B8A7-5539-4190-85BF-A3CC1553519CQ33916355-B8E93DC2-4B0F-401E-8454-E82D37752EBCQ33921227-8213B101-7644-4ABF-8C9C-281A58665D38Q34031173-9BCA172A-54BC-4B78-985A-9AF070B493D8Q34071168-E0E76ED8-F7F0-47E4-BAD7-298A87FD4D77Q34077702-F90589F0-FE7D-4A4D-911F-E0F345786A7EQ34082969-0C65DD06-3701-41EB-A19D-2ABF9E3068CDQ34090397-45B35513-D726-4082-A38F-D94ADD60E23FQ34102424-684C6046-D96B-4115-A1A8-20FC7238C675Q34126545-63E4871D-416B-4175-9BE5-D5EDC0AB201EQ34154129-6BE257D1-23B8-4158-ACB3-435DDCBE7E3AQ34162204-BBEEA5FD-FCA5-4C5C-9BA2-7D4F78206248Q34163174-022D6122-04D6-4742-93A4-28C7AC141FFDQ34339533-B65808FC-AEE9-41F8-89C1-578B984089A4Q34340748-922E01EB-6E5A-4FD8-BCDA-904F28E89AA2Q34485535-82AAFBA4-C08A-4D7A-82D9-D7004525F753Q34544751-97CA4B60-E10D-4AB1-BB3E-B6F25FFAD3E2Q34584051-303B8B5B-E74B-43DC-B1FA-12D0AE22031FQ34712785-57AD78C3-B76D-4D2F-B9C9-98E7A09B7168Q34718341-D5D0F290-4D9F-4F17-9C67-2E5C1EB7462AQ34756298-D6163109-52F5-4F72-91F6-872240B05B39Q34767070-03047884-ECF0-439A-9C1C-AD6A6F9CCBD1Q34774978-8FA79130-C48A-4A93-ABFA-C8EAAEDE5AA0Q35003539-72C1E778-D1FA-4A54-8E94-A5F220D66D53Q35019915-5781517B-1335-493A-8E78-FE90FC3873A8Q35119311-96F685DF-F295-4DE5-9AF2-F13BFA1C5564
P2860
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Expanded access to highly acti ...... he growth of the HIV epidemic.
@en
Expanded access to highly acti ...... he growth of the HIV epidemic.
@nl
type
label
Expanded access to highly acti ...... he growth of the HIV epidemic.
@en
Expanded access to highly acti ...... he growth of the HIV epidemic.
@nl
prefLabel
Expanded access to highly acti ...... he growth of the HIV epidemic.
@en
Expanded access to highly acti ...... he growth of the HIV epidemic.
@nl
P2093
P356
P1476
Expanded access to highly acti ...... he growth of the HIV epidemic.
@en
P2093
Adrian R Levy
Aranka Anema
Karissa Johnston
P Richard Harrigan
Viviane D Lima
P356
10.1086/588673
P407
P577
2008-07-01T00:00:00Z